Stay updated on Pembrolizumab for Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Metastatic TNBC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now shows revision v3.5.4, replacing the previous v3.5.3, indicating a small update to the page metadata or content.
    Difference
    0.1%
    Check dated 2026-05-15T15:12:06.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance or release update rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:57:29.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:31:47.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 with no visible changes to the Study Details page.
    Difference
    0.1%
    Check dated 2026-03-19T05:17:43.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:19:00.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed older notices including Revision: v3.4.1 and the government funding status banner.
    Difference
    0.4%
    Check dated 2026-02-11T14:29:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic TNBC Clinical Trial page.